idazoxan has been researched along with Anochlesia in 7 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (14.29) | 18.2507 |
| 2000's | 5 (71.43) | 29.6817 |
| 2010's | 1 (14.29) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Alam, M; Danysz, W; Dekundy, A; Schmidt, WJ | 1 |
| Frånberg, O; Jardemark, K; Konradsson-Geuken, A; Langlois, X; Marcus, MM; Svensson, TH; Wiker, C | 1 |
| Garavaglia, C; Invernizzi, RW; Samanin, R | 1 |
| Schmidt, WJ; Srinivasan, J | 2 |
| Svensson, TH; Wadenberg, ML; Wiker, C | 1 |
| Fagerquist, MV; Hertel, P; Svensson, TH | 1 |
7 other study(ies) available for idazoxan and Anochlesia
| Article | Year |
|---|---|
Effects of glutamate and alpha2-noradrenergic receptor antagonists on the development of neurotoxicity produced by chronic rotenone in rats.
Topics: Adrenergic alpha-2 Receptor Antagonists; Adrenergic alpha-Antagonists; Animals; Basal Ganglia; Behavior, Animal; Catalepsy; Cyclopentanes; Disease Models, Animal; Dopamine; Excitatory Amino Acid Antagonists; Hypokinesia; Idazoxan; Male; Motor Activity; Muscle Rigidity; Neuroprotective Agents; Neurotoxicity Syndromes; Parkinsonian Disorders; Pyridines; Rats; Rats, Sprague-Dawley; Receptor, Metabotropic Glutamate 5; Receptors, Adrenergic, alpha-2; Receptors, Metabotropic Glutamate; Receptors, N-Methyl-D-Aspartate; Rotenone; Serotonin; Substantia Nigra; Time Factors | 2009 |
Adjunctive alpha2-adrenoceptor blockade enhances the antipsychotic-like effect of risperidone and facilitates cortical dopaminergic and glutamatergic, NMDA receptor-mediated transmission.
Topics: Adrenergic alpha-2 Receptor Antagonists; Animals; Antipsychotic Agents; Avoidance Learning; Catalepsy; Cerebral Cortex; Dopamine Agonists; Electrophysiological Phenomena; Excitatory Amino Acid Agents; Idazoxan; Male; Microdialysis; Rats; Rats, Sprague-Dawley; Rats, Wistar; Receptors, N-Methyl-D-Aspartate; Risperidone; Synaptic Transmission | 2010 |
The alpha 2-adrenoceptor antagonist idazoxan reverses catalepsy induced by haloperidol in rats independent of striatal dopamine release: role of serotonergic mechanisms.
Topics: Adrenergic alpha-2 Receptor Antagonists; Catalepsy; Corpus Striatum; Dopamine; Dose-Response Relationship, Drug; Haloperidol; Idazoxan; Neurons; Receptors, Adrenergic, alpha-2; Receptors, Serotonin; Receptors, Serotonin, 5-HT1; Serotonin | 2003 |
The effect of the alpha2-adrenoreceptor antagonist idazoxan against 6-hydroxydopamine-induced Parkinsonism in rats: multiple facets of action?
Topics: Adrenergic alpha-Antagonists; Animals; Antiparkinson Agents; Brain; Catalepsy; Disease Models, Animal; Dopamine; Exploratory Behavior; Hydroxyindoleacetic Acid; Idazoxan; Male; Motor Activity; Oxidopamine; Parkinsonian Disorders; Prefrontal Cortex; Rats; Rats, Sprague-Dawley; Serotonin; Time Factors | 2004 |
Treatment with alpha2-adrenoceptor antagonist, 2-methoxy idazoxan, protects 6-hydroxydopamine-induced Parkinsonian symptoms in rats: neurochemical and behavioral evidence.
Topics: Adrenergic alpha-Antagonists; Analysis of Variance; Animals; Brain Chemistry; Catalepsy; Disease Models, Animal; Dopamine; Drug Interactions; Hydroxyindoleacetic Acid; Idazoxan; Male; Motor Activity; Norepinephrine; Oxidopamine; Parkinsonian Disorders; Rats; Rats, Sprague-Dawley; Reaction Time; Serotonin; Statistics, Nonparametric | 2004 |
Enhanced efficacy of both typical and atypical antipsychotic drugs by adjunctive alpha2 adrenoceptor blockade: experimental evidence.
Topics: Adrenergic alpha-2 Receptor Antagonists; Adrenergic alpha-Antagonists; Animals; Antipsychotic Agents; Avoidance Learning; Benzodiazepines; Catalepsy; Dopamine; Dose-Response Relationship, Drug; Drug Synergism; Dyskinesia, Drug-Induced; Haloperidol; Idazoxan; Male; Microdialysis; Motor Activity; Nucleus Accumbens; Olanzapine; Prefrontal Cortex; Rats; Rats, Wistar | 2007 |
Enhanced cortical dopamine output and antipsychotic-like effects of raclopride by alpha2 adrenoceptor blockade.
Topics: Adrenergic alpha-2 Receptor Antagonists; Adrenergic alpha-Antagonists; Animals; Antipsychotic Agents; Avoidance Learning; Catalepsy; Conditioning, Psychological; Corpus Striatum; Dopamine; Dopamine Antagonists; Dose-Response Relationship, Drug; Drug Synergism; Idazoxan; Nucleus Accumbens; Prefrontal Cortex; Raclopride; Rats; Receptors, Adrenergic, alpha-2; Salicylamides; Schizophrenia | 1999 |